Skip to main content
OpenTrials
Completed

NCT Number: NCT01608659

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Facial Rhytides

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Buenos Aires, Argentina

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Previously treated for glabellar lines (hyperfunctional facial lines) with botulinum toxin Type A preparation
  • Received 2 treatment cycles wtih botulinum toxin Type A (BOTOX®) prior to at least 1 treatment with botulinum toxin Type A (Xeomin®)

Exclusion criteria

  • None

Treatment and study plan

Botulinum Toxin Type A

Drug

Previous treatment with botulinum toxin Type A for treatment of facial lines

Other names: BOTOX®, Xeomin®

Primary outcomes

  1. Average Total Dose Per Treatment Period

    Time frame: 24 Months

    Average total dose per treatment period was defined as total treatment dose plus total touch-up dose plus total follow-up dose.

Secondary outcomes

  1. Inter-Injection Interval Duration of Each Treatment Period

    Time frame: 24 Months

    Inter-injection interval duration of each treatment period. Duration is defined as the number of days of an injection cycle.

  2. Percent of Subjects Reporting Satisfaction With Treatment Effects

    Time frame: 24 Months

    Percent of subjects reporting satisfaction with treatment effects per chart notes.

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
May 31, 2012
Registry last updated
Apr 17, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.